Evidence map›Paper›PMID 38146588›Full record

ArticlePathology oncology research : POR2023

Comparative analysis of EZH2, p16 and p53 expression in uterine carcinosarcomas.

Evelin Makk, Noémi Bohonyi, Angéla Oszter, Klára Éles, Tamás Tornóczky, Arnold Tóth, Endre Kálmán, Krisztina Kovács

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathology oncology research : POR, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Evelin MakkDepartment of Pathology, University of Pécs Medical School, Pécs, Hungary.
Noémi BohonyiDepartment of Obstretrics and Gynaecology, University of Pécs Medical School, Pécs, Hungary.
Angéla OszterDepartment of Pathology, University of Pécs Medical School, Pécs, Hungary.
Klára ÉlesDepartment of Pathology, University of Pécs Medical School, Pécs, Hungary.
Tamás TornóczkyDepartment of Pathology, University of Pécs Medical School, Pécs, Hungary.
Arnold TóthDepartment of Medical Imaging, University of Pécs Medical School, Pécs, Hungary.
Endre KálmánDepartment of Pathology, University of Pécs Medical School, Pécs, Hungary.
Krisztina KovácsDepartment of Pathology, University of Pécs Medical School, Pécs, Hungary.
University of Pecs · HU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CarcinosarcomaCyclin-Dependent Kinase Inhibitor p16Enhancer of Zeste Homolog 2 ProteinGene Expression Regulation, NeoplasticTumor Suppressor Protein p53Uterine NeoplasmsAgedAged, 80 and overBiomarkers, TumorFemaleGene Expression ProfilingHumansMiddle AgedBiomarkers, TumorCDKN2A protein, humanCyclin-Dependent Kinase Inhibitor p16Enhancer of Zeste Homolog 2 ProteinEZH2 protein, humanTumor Suppressor Protein p53carcinosarcomaEZH2p16p53uterine cancer

Identifiers

PMID38146588
PMCPMC10749357
OpenAlexW4389570270

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.